You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol

Citation Tools

Article menu

Download PDFPDF

XML
Oncology
Protocol
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Vatandoust S, Bright T, Roy AC, et al
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol
BMJ Open 2019;9:e026732. doi: 10.1136/bmjopen-2018-026732